Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized indocyanine green-guided fluorescence imaging for pulmonary nodules
ChiCTR2200064107Phase 3Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of indocyanine green in bronchial carcinoma and lung nodule (SPN) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Nodule exploration time. Started Aug 2022; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
bronchial carcinomalung nodule (SPN)
Beyond the preview
Go deeper on ChiCTR2200064107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064107.